- Home
- EHC vs ASND Comparison
EHC vs ASND Comparison
Compare EHC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- ASND
- Stock Information
- Founded
- EHC 1983
- ASND 2006
- Country
- EHC United States
- ASND Denmark
- Employees
- EHC N/A
- ASND N/A
- Industry
- EHC Hospital/Nursing Management
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- EHC Health Care
- ASND Health Care
- Exchange
- EHC Nasdaq
- ASND Nasdaq
- Market Cap
- EHC 12.4B
- ASND 12.2B
- IPO Year
- EHC 1986
- ASND 2015
- Fundamental
- Price
- EHC $113.00
- ASND $209.85
- Analyst Decision
- EHC Strong Buy
- ASND Strong Buy
- Analyst Count
- EHC 8
- ASND 15
- Target Price
- EHC $141.88
- ASND $256.27
- AVG Volume (30 Days)
- EHC 946.3K
- ASND 528.4K
- Earning Date
- EHC 10-29-2025
- ASND 11-12-2025
- Dividend Yield
- EHC 0.67%
- ASND N/A
- EPS Growth
- EHC 27.89
- ASND N/A
- EPS
- EHC 5.29
- ASND N/A
- Revenue
- EHC $5,795,600,000.00
- ASND $758,592,045.00
- Revenue This Year
- EHC $11.54
- ASND $104.98
- Revenue Next Year
- EHC $8.79
- ASND $79.91
- P/E Ratio
- EHC $21.37
- ASND N/A
- Revenue Growth
- EHC 11.13
- ASND 97.46
- 52 Week Low
- EHC $87.85
- ASND $118.03
- 52 Week High
- EHC $127.99
- ASND $223.19
- Technical
- Relative Strength Index (RSI)
- EHC 34.35
- ASND 54.09
- Support Level
- EHC $110.69
- ASND $208.01
- Resistance Level
- EHC $116.11
- ASND $223.19
- Average True Range (ATR)
- EHC 2.57
- ASND 10.26
- MACD
- EHC -0.28
- ASND 1.18
- Stochastic Oscillator
- EHC 25.41
- ASND 59.66
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.